Literature DB >> 10838114

Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child.

H Yoshikawa1, T Watanabe, T Abe, Y Oda, K Ozawa.   

Abstract

A 6-year-old severely handicapped boy with haloperidol-induced mild rhabdomyolysis without neuroleptic malignant syndrome is reported. He had suffered from frontal lobe epilepsy, severe mental retardation and involuntary movements. To reduce the involuntary movements, oral administration of haloperidol was started. Haloperidol was effective for the involuntary movements, and he became well. However, his urine was sometimes dark brown, and the myoglobin level in his urine was increased. After discontinuation of haloperidol, his urine never became dark brown. It was suspected that haloperidol might cause mild rhabdomyolysis without neuroleptic malignant syndrome. Neuroleptic malignant syndrome is a rare but severe adverse effect of neuroleptics, and is usually accompanied by rhabdomyolysis. Although there have been a few adult cases presenting rhabdomyolysis without neuroleptic malignant syndrome, this patient might be the first child case with such symptoms. We have to pay attention to this syndrome when using haloperidol even in children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10838114     DOI: 10.1016/s0387-7604(00)00103-0

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  3 in total

Review 1.  Accidental and iatrogenic causes of acute kidney injury.

Authors:  Katherine Twombley; Michel Baum; Jyothsna Gattineni
Journal:  Curr Opin Pediatr       Date:  2011-04       Impact factor: 2.856

2.  Rhabdomyolysis with erratic serum creatinin phosphokinase levels: intramuscular injection of haloperidol decanoate.

Authors:  Premnath Reddy Karre; Jeetinder Gujral; Ernesto Rodriguez
Journal:  BMJ Case Rep       Date:  2009-08-17

3.  A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19.

Authors:  Keisuke Takada; Yukiyoshi Sada; Masaru Samura; Masashi Matsuura; Naoki Hirose; Takenori Kurata; Fumio Nagumo; Junichi Ishii; Sakura Koshioka; Masaki Uchida; Junki Inoue; Koji Tanikawa; Hiroyuki Kunishima
Journal:  Am J Case Rep       Date:  2022-06-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.